Home > Insider Trading > Filing (0000921503-13-000100)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921503	Blyth Inc	BTH	Pharmaceutical Preparations (2834)	362984916

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1382293	Andrew Todd Goergen	1 East Weaver Street Greenwich CT 06831		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common	Acquisiton	2013-09-17	20,000	$12.34	60,830	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common	80,000	Indirect	By TAGAPT, LLC
Common	263,184	Indirect	By Trust MCT
Common	1,352,750	Indirect	By Ropart Investments, LLC
Common	33,714	Indirect	By Trust for Brother
Common	3,600	Indirect	Spousal
Common	2,605	Indirect	By Trust for Children
Common	33,714	Indirect	By Trust
Common	101,146	Indirect	By Trust for Children and Brother's Children

Footnotes

Represents a weighted average purchase price for transactions reported on this date. The range of prices for transactions reported in this line is: $12.20 to $12.45. The reporting person undertakes to provide upon request by the Securites and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.